Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Christopher Duane Nevala-Plagemann"'
Autor:
Shashank Sama, Christopher Duane Nevala-Plagemann, Jarrod Smith, Lisa M. Pappas, Benjamin Haaland, Ignacio Garrido-Laguna
Publikováno v:
Journal of Clinical Oncology. 41:313-313
313 Background: Current guidelines recommend an upfront cytotoxic doublet with or without targeted therapy or immunotherapy for the management of patients with advanced gastroesophageal adenocarcinoma (aGEA).While evidence for the superiority of comb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91f50ba381f1597ccf1e8cf2519c65d8
https://doi.org/10.1200/jco.2023.41.4_suppl.313
https://doi.org/10.1200/jco.2023.41.4_suppl.313
Autor:
Christopher Duane Nevala-Plagemann, Jian Ying, Shashank Sama, Vaia Florou, Benjamin Haaland, Ignacio Garrido-Laguna
Publikováno v:
Journal of Clinical Oncology. 40:39-39
39 Background: For patients with refractory metastatic colorectal cancer (mCRC), both trifluridine/tipiracil (TAS-102) and regorafenib have received approval for use in the United States. The approvals of these agents were based on modest improvement
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::555c642bbf62f3c4f4164deddc110fc3
https://doi.org/10.1200/jco.2022.40.4_suppl.039
https://doi.org/10.1200/jco.2022.40.4_suppl.039